OxySure Systems (OXYS) Adds Chile To Fast Growing Global Distribution Footprint

FRISCO, Texas, December 11, 2013, 2013 (MarketWired) -- OxySure(R) Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that it has signed a distribution agreement with Tecnología Contra Incendios Python E.I.R.L. (“Python”) to represent OxySure in the country of Chile in South America. This is the first distribution agreement announced by OxySure post-Medica 2013, the international medical tradeshow where the Company exhibited in Dusseldorf, Germany during November 2013.

Based in Santiago, the capital of Chile, Python sells safety equipment and supplies to mining and manufacturing companies, service organizations, government departments, some health centers and fire and traffic departments. Python’s products include first aid, rescue and emergency products, safety cans and cabinets, fire fighting products, spill containment products, and traffic managements products. The distribution agreement is non-exclusive and contains minimum annual order quantity provisions.

“We are pleased to add Python to our to our fast growing list of international distribution partners,” stated Mr. Julian Ross, CEO of OxySure. “Chile is considered one of South America's most stable and prosperous nations, with a population of approximately 17.4 million people. Python has a good understanding of the first aid and safety market segments in Chile.”

About OxySure Systems, Inc. 

OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com

Forward-Looking Statements 

Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management's control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.'s Annual Report on Form 10-K for the year ended December 31, 2012.

Investor Contact: 

Christian Hansen

Maximum Performance Advisors, Inc.

858-381-4677

This email address is being protected from spambots. You need JavaScript enabled to view it.